Neural Basis of the Effect of Eye Movement Desensitization and Reprocessing (EMDR) Therapy on Cognition in Patients With Post-Traumatic Stress Disorder
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 46
- 试验地点
- 1
- 主要终点
- LPP
研究概览
简要总结
This study aimed to investigate the effects of a single session of Butterfly Tapping (BT), a self-administered form of alternating bilateral stimulation, on emotional reactivity and its neurophysiological correlates. 46 participants will be randomly assigned to an experimental (Exp) or control (Con) group. The Exp group performed a 15-minute session of BT. Emotional reactivity was assessed before and after the stimulation using a detection task with emotional visual stimuli, presented during electroencephalographic (EEG) recording. EEG analyses were conducted using the event-related potential (ERP) method, specifically focusing on the differential amplitude (negative minus neutral) of the Late Positive Potential (LPP), a centro-parietal component associated with sustained processing of emotionally salient stimuli. Results revealed a significant LPP reduction in the Exp group at T1 compared to T0, whereas no change emerged in the Con group. The topographical distribution of the modulation was predominantly central, consistent with models implicating the LPP in higher-order integrative and evaluative processes. These findings provide preliminary neurophysiological evidence that BT may reduce cortical reactivity to negative emotional stimuli in young clinical populations, supporting its potential as a simple and accessible strategy capable of modulating affective responsiveness.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •normal or corrected-to-normal vision; full right-handedness
排除标准
- •neurological or other psychiatric disorders tha PTSD; current use of psychoactive medications.
研究组 & 干预措施
Butterfly Tapping
Participants assigned to the Experimental Group (Exp) will perform a self-administered session of Butterfly Tapping (BT), a form of alternating bilateral tactile stimulation widely used in Eye Movement Desensitization and Reprocessing (EMDR)-derived affect-regulation techniques. This arm was designed to test whether rhythmic bilateral sensory input modulates neural indices of emotional reactivity.
干预措施: Butterfly Tapping (BT) (Behavioral)
No tapping (Control Group)
Participants assigned to the Control Group will maintain the same posture as the experimental group but will not perform any tapping. This static condition controls for posture, context, expectancy, and emotional activation, isolating the specific effect of the bilateral stimulation.
干预措施: No intervention control (Behavioral)
结局指标
主要结局
LPP
时间窗: Baseline, End of Treatment (8-12 weeks), and Follow-up (8 weeks after treatment completion)
Late Positive Potential (LPP) Differential Amplitude (Negative - Neutral) The primary neurophysiological outcome will be the modulation of the centro-parietal Late Positive Potential (LPP), extracted from EEG recordings during the Emotional Simple Response Task (E-SRT). The LPP is a well-established marker of sustained attentional and evaluative processing of emotional stimuli. For each participant and time point (T0, T1, T2), ERP waveforms willbe computed separately for negative and neutral images, and difference waves (negative minus neutral) were used to isolate emotion-specific neural reactivity. Primary analyses focused on mean amplitudes in the experimentally defined cLPP time window (456-552 ms) over the centro-parietal electrode cluster (Cz, C1, C2, CP1, CPz, CP2). The primary contrast of interest was the Group × Time interaction, assessing whether a single session of Butterfly Tapping selectively reduced the LPP differential amplitude relative to the static control condition.
次要结局
- Frontal positivity(Baseline, End of Treatment (8-12 weeks), and Follow-up (8 weeks after treatment completion))
- Behavior(Baseline, End of Treatment (8-12 weeks), and Follow-up (8 weeks after treatment completion))
- Self-report(Baseline, End of Treatment (8-12 weeks), and Follow-up (8 weeks after treatment completion))
